The 26 references in paper M. Lyndina L., A. Shishkin N., V. Volovnikova A., М. Линдина Л., А. Шишкин Н., В. Воловникова А. (2015) “ОСОБЕННОСТИ ВНУТРИПОЧЕЧНОЙ ГЕМОДИНАМИКИ У ПАЦИЕНТОВ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ // FEATURES OF RENAL HEMODYNAMICS IN PATIENTS WITH METABOLIC SYNDROME” / spz:neicon:nefr:y:2015:i:4:p:82-88

1
Alberti KG, Eckel RH, Grundy SM et al. International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the study of Obesity. Circulation 2009 Oct 20; 120 (16): 1640-1645
(check this in PDF content)
2
G V Ramesh Prasad. Metabolic syndrome and chronic kidney disease: current status and future directions. World journal of Nephrology Nov 6, 2014; 3(4): 210-219
(check this in PDF content)
3
Browmik D, Tiwari SC. Metabolic syndrome and chronic kidney disease. Indian JNephrol 2008 Jan; 18 (1):1-4
(check this in PDF content)
4
Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in metabolic syndrome. JAm Soc Nephrol 2006 Apr; 17(4 Suppl 2): 81-85
(check this in PDF content)
5
Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999 Sep; 56 (3): 860-872
(check this in PDF content)
6
Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J, Kitamura M. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. JBiol Chemistry 2000 Apr 28; 275(17): 12684-12691
(check this in PDF content)
7
Serra A, Romero R, Lopez D, Navarro M et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008 Apr; 73 (8): 947-955
(check this in PDF content)
8
Cao Z, Cooper ME. Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 2001; 21 (6): 554-562
(check this in PDF content)
9
Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am JPhysiol Renal Physiol 2007; 292 (1): F423- 429
(check this in PDF content)
10
Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes Metab Res Rev 2010; 26 (1): 26-32
(check this in PDF content)
11
Thomas G, Sehgal AR, Kashyap SR et al. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clinical JAmSocNephrol 2011; 6(10): 2364-2373
(check this in PDF content)
12
Ryu S, Chang Y, Woo HY et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009; 53 (1): 59-69
(check this in PDF content)
13
Bonnet F, Marre M, Halimi JM et al, DESIR Study. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. Group. JHypertension 2006; 24 (6): 1157-1163
(check this in PDF content)
14
Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am JHypertension 2003; 16 (11 Pt 1): 952-958
(check this in PDF content)
15
Alexander MP, Patel TV, Farag YM et al. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am JKidney Dis 2009; 53 (5): 751-759
(check this in PDF content)
16
Buscemi S, Verga S, Batsis JA et al. Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome. Diabetes Research Clinical Practice 2009; 86 (3): 177-185
(check this in PDF content)
17
Литвин А. Микроальбуминурия: клиническое значение. Врач 2011; 9: 7-13. [Litvin A. Mikroalbuminuriya: klinicheskoye znacheniye. Vrach 2011; 9: 7-13]
(check this in PDF content)
18
Клиническое руководство по ультразвуковой диагностике (в 2-х томах под ред. В.В.Митькова). 1 том, М.: Видар, 1996, 336 с. [Klinicheskoe rukovodstvo po ultrazvukuvoy diagnostike (v 2-h tomah pod red. V.V.Mitkova). 1 tom, M.: Vidar,
(check this in PDF content)
19
6, 336 s 19. Celermajer DS. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 1998; 32 (Suppl.)3:S29-32
(check this in PDF content)
20
Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue – a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002; 17: 191–195
(check this in PDF content)
21
Praga M. Obesity – a neglected culprit in renal disease. Nephrol Dial Transplant 2002; 17:1157-1159
(check this in PDF content)
22
Лындина МЛ, Шишкин АН, Тесля ОВ. Особенности ранней диагностики эндотелиальной дисфункции у больных с метаболически мсиндромом. Вестник С.-Петерб. у-та. Серия 11. 2014; Выпуск 3: 56-65. [Lyndina ML, Shishkin AN, Teslya OV. Osobennosti ranney diagnostiki endotelialnoy disfunktsii u bolnykh s metabolicheskim sindromom. VestnikS.-Peterb.u-ta. Seriya 11. 2014. Vypusk 3. S.56-65.]
(check this in PDF content)
23
Шишкин АН, Лындина МЛ. Эндотелиальная дисфункция, метаболический синдром и микроальбуминурия. Нефрология 2009; 13(3): 24-32 [Shishkin AN, Lyndina ML. Endotelialnaya disfunktsiya, metabolicheskiy sindrom I mikroalbuminuriya. Nefrologiya 2009; 13(3): 24-32]
(check this in PDF content)
24
Jassal SK, Langenberg C, vonMulen D, Bergstrom О et al. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men > 40 years of age (from the Rancho Bernardo Study). Am О Cardiol 2008; 101: 1275-1280
(check this in PDF content)
25
Шестакова МВ. Дисфункция эндотелия – причина или следствие метаболического синдрома? РМЖ 2001; 9 (2): 88-90 [Shestakova MV. Disfunktsiya endoteliya – prichina ili sledstviye metabolicheskogo sindroma? RMZh 2001; 9 (2): 88-90]
(check this in PDF content)
26
Lippincot MF, Carlow A, Desai A, Blum A, Rodrigo M et al. Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. The Am Coll of Cardiol 2008; 102, (issue 3) 83-122 Авторы заявляют об отсутствии конфликта
(check this in PDF content)